HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Millaray Marincevic Selected Research

Thyroid Nuclear Factor 1

11/2014Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Millaray Marincevic Research Topics

Disease

2Neoplasms (Cancer)
01/2015 - 11/2014
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2010 - 09/2010
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2022
1Adenocarcinoma of Lung
11/2014
1Large Cell Carcinoma
11/2014
1Carcinoma (Carcinomatosis)
11/2014
1Adenocarcinoma
11/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2014

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2015 - 11/2014
1Immunoglobulins (Immunoglobulin)IBA
06/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
06/2022
1EnzymesIBA
01/2015
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2015
1claudin 6IBA
11/2014
1Messenger RNA (mRNA)IBA
11/2014
1Thyroid Nuclear Factor 1IBA
11/2014
1Protein Isoforms (Isoforms)IBA
11/2014
1Complementarity Determining Regions (Complementarity Determining Region)IBA
12/2010
1AntigensIBA
09/2010

Therapy/Procedure

1Therapeutics
11/2014